vulvovaginit candidiasis. Vulvovaginal ulceration and inflammation in diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: treatment with vaginal cream 0/1% Artemisia- Built in the Pharmacy School of Mashhad University of Medical Sciences-one applicator every night for a week-Interventi
Treatment - Drugs
Intervention group: treatment with vaginal cream 0/1% Artemisia- Built in the Pharmacy School of Mashhad University of Medical Sciences-one applicator every night for a week-Intervention group
Control group: Treatment with vaginal cream Clotrimazole 1%- production of Aboreahan company-an applicator every night for a week-control group
Sponsors
Mashhad University of Medical Sciences - Deputy of Research and Technology
Eligibility
Sex/Gender
Female
Age
15 Years to 49 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: signs and symptoms of Candida vaginitis? positive culture and wet smear of vaginal discharge. Exclusion criteria: pregnancy? hypersensitivity to clotrimasol or artemisia? recurrent Candida vaginitis (4 or more Candida vaginitis in a year)? consumption of immunosuppressive drugs or systemic antibiotics? history of diabetes? using vaginal creams 2 weeks prior to the study? consumption of systemic anti-fungal drugs during 2 weeks prior to the study? presence of non-candidia vaginitis? consumption of oral contraceptives.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Discharge. Timepoint: Baseline, 1 week+_24 hours after treatment. Method of measurement: Clinical Examination, observation, and medical history. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pruritus. Timepoint: Baseline, 1 week+_24hours after treatment. Method of measurement: History.;Erythema symptoma. Timepoint: Baseline, 1 week _+24 hours after treatment. Method of measurement: Observation, and History.;Dysuria. Timepoint: Baseline, 1 week+_24 hours after treatment. Method of measurement: History.;Dysparonia Symptom. Timepoint: Baseline, 1 week+_ 24hours after treatment. Method of measurement: History.;Vaginal Culture. Timepoint: Baseline, 1 week+_24 hours after treatment. Method of measurement: Vaginal Culture. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAla sabermahammad
School of Nursing and Midwifery
Outcome results
None listed